HUP0004150A3 - Indazole derivatives as tyrosine kinase receptor antagonists and pharmaceutical compositions containing them - Google Patents
Indazole derivatives as tyrosine kinase receptor antagonists and pharmaceutical compositions containing themInfo
- Publication number
- HUP0004150A3 HUP0004150A3 HU0004150A HUP0004150A HUP0004150A3 HU P0004150 A3 HUP0004150 A3 HU P0004150A3 HU 0004150 A HU0004150 A HU 0004150A HU P0004150 A HUP0004150 A HU P0004150A HU P0004150 A3 HUP0004150 A3 HU P0004150A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- tyrosine kinase
- receptor antagonists
- kinase receptor
- Prior art date
Links
- 102000004278 Receptor Protein-Tyrosine Kinases Human genes 0.000 title 1
- 108090000873 Receptor Protein-Tyrosine Kinases Proteins 0.000 title 1
- 125000003453 indazolyl group Chemical class N1N=C(C2=C1C=CC=C2)* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6422997P | 1997-11-04 | 1997-11-04 | |
| US6402497P | 1997-11-04 | 1997-11-04 | |
| US6422897P | 1997-11-04 | 1997-11-04 | |
| US6418797P | 1997-11-04 | 1997-11-04 | |
| US6419897P | 1997-11-04 | 1997-11-04 | |
| PCT/IB1998/001710 WO1999023077A1 (en) | 1997-11-04 | 1998-10-26 | Indazole bioisostere replacement of catechol in therapeutically active compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0004150A2 HUP0004150A2 (hu) | 2001-05-28 |
| HUP0004150A3 true HUP0004150A3 (en) | 2001-08-28 |
Family
ID=27535645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0004150A HUP0004150A3 (en) | 1997-11-04 | 1998-10-26 | Indazole derivatives as tyrosine kinase receptor antagonists and pharmaceutical compositions containing them |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6391872B1 (hu) |
| EP (1) | EP1028946A1 (hu) |
| JP (1) | JP2001521926A (hu) |
| CN (1) | CN1284948A (hu) |
| AP (1) | AP910A (hu) |
| AR (1) | AR013746A1 (hu) |
| AU (1) | AU754734B2 (hu) |
| BG (1) | BG104450A (hu) |
| BR (1) | BR9813926A (hu) |
| CA (1) | CA2309150A1 (hu) |
| CZ (1) | CZ20001621A3 (hu) |
| DZ (1) | DZ2640A1 (hu) |
| EA (1) | EA200000488A1 (hu) |
| HR (1) | HRP20000253A2 (hu) |
| HU (1) | HUP0004150A3 (hu) |
| ID (1) | ID23921A (hu) |
| IL (1) | IL135900A0 (hu) |
| IS (1) | IS5465A (hu) |
| MA (1) | MA26563A1 (hu) |
| NO (1) | NO20002129L (hu) |
| NZ (1) | NZ503918A (hu) |
| OA (1) | OA11354A (hu) |
| PE (1) | PE129199A1 (hu) |
| PL (1) | PL340753A1 (hu) |
| SK (1) | SK6252000A3 (hu) |
| TN (1) | TNSN98200A1 (hu) |
| TR (1) | TR200001234T2 (hu) |
| WO (1) | WO1999023077A1 (hu) |
| YU (1) | YU25000A (hu) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0100330A3 (en) * | 1997-11-04 | 2002-03-28 | Pfizer Prod Inc | Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors, compositions containing them and their use |
| UA71971C2 (en) | 1999-06-04 | 2005-01-17 | Agoron Pharmaceuticals Inc | Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases |
| TWI262914B (en) | 1999-07-02 | 2006-10-01 | Agouron Pharma | Compounds and pharmaceutical compositions for inhibiting protein kinases |
| PE20010306A1 (es) * | 1999-07-02 | 2001-03-29 | Agouron Pharma | Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa |
| US7141581B2 (en) | 1999-07-02 | 2006-11-28 | Agouron Pharmaceuticals, Inc. | Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| JP2001031549A (ja) * | 1999-07-14 | 2001-02-06 | Pola Chem Ind Inc | 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料 |
| US6432979B1 (en) | 1999-08-12 | 2002-08-13 | American Cyanamid Company | Method of treating or inhibiting colonic polyps and colorectal cancer |
| WO2001012227A1 (en) * | 1999-08-12 | 2001-02-22 | American Cyanamid Company | Nsaid and efgr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer |
| YU54202A (sh) | 2000-01-18 | 2006-01-16 | Agouron Pharmaceuticals Inc. | Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije |
| HN2001000008A (es) | 2000-01-21 | 2003-12-11 | Inc Agouron Pharmaceuticals | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo |
| US7005443B1 (en) * | 2000-03-17 | 2006-02-28 | Alcon, Inc. | 5-Hydroxy indazole derivatives for treating glaucoma |
| WO2001079198A1 (en) | 2000-04-18 | 2001-10-25 | Agouron Pharmaceuticals, Inc. | Pyrazoles for inhibiting protein kinase |
| EP1380576B1 (en) | 2001-04-16 | 2009-11-25 | Eisai R&D Management Co., Ltd. | 1h-indazole compounds inhibiting jnk |
| MXPA04002562A (es) | 2001-09-19 | 2004-05-31 | Altana Pharma Ag | Combinacion de un pde-4 y nsaid. |
| WO2003024456A1 (en) * | 2001-09-20 | 2003-03-27 | Eisai Co., Ltd. | Methods for treating and preventing migraines |
| EP1479138A2 (en) * | 2002-02-13 | 2004-11-24 | Koninklijke Philips Electronics N.V. | Integrated semiconductor optical device, method and apparatus for manufacturing such a device |
| US7108868B2 (en) | 2002-03-22 | 2006-09-19 | Unigen Pharmaceuticals, Inc. | Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
| US7972632B2 (en) | 2003-02-28 | 2011-07-05 | Unigen Pharmaceuticals, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
| US8034387B2 (en) | 2002-04-30 | 2011-10-11 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
| JP4723239B2 (ja) * | 2002-04-30 | 2011-07-13 | ユニジェン・インコーポレーテッド | 治療剤としての遊離−ｂ−環フラボノイド類とフラバン類との混合物の製剤 |
| CA2507074A1 (en) | 2002-12-02 | 2004-06-17 | F. Hoffmann-La Roche Ag | Indazole derivatives as crf antagonists |
| NZ541699A (en) | 2003-02-14 | 2009-01-31 | Wyeth Corp | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| US7135575B2 (en) | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| WO2004089392A1 (en) * | 2003-04-04 | 2004-10-21 | Unigen Pharmaceuticals, Inc. | Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care |
| US6984652B2 (en) * | 2003-09-05 | 2006-01-10 | Warner-Lambert Company Llc | Gyrase inhibitors |
| CA2557575A1 (en) | 2004-02-27 | 2005-09-15 | F. Hoffmann-La Roche Ag | Fused derivatives of pyrazole |
| WO2005085206A1 (en) | 2004-02-27 | 2005-09-15 | F. Hoffmann-La Roche Ag | Indazole derivatives and pharmaceutical compositions containing them |
| AU2005219517A1 (en) | 2004-02-27 | 2005-09-15 | F.Hoffmann-La Roche Ag | Heteroaryl-fused pyrazolo derivatives |
| US7844309B2 (en) * | 2004-02-27 | 2010-11-30 | Nokia Corporation | Exchangeable keymat |
| US7601847B2 (en) | 2004-10-26 | 2009-10-13 | Wyeth | Preparation and purification of 4-(indazol-3-yl)phenols |
| WO2006056873A2 (en) * | 2004-11-29 | 2006-06-01 | Warner-Lambert Company Llc | Therapeutic pyrazolo[3,4-b] pyridines and indazoles |
| RU2008103700A (ru) * | 2005-08-15 | 2009-09-27 | Вайет (Us) | Производные азинил-3-сульфонилиндазола в качестве лиганд 5ов 5-гидрокситриптамина-6 |
| BRPI0614343A2 (pt) * | 2005-08-15 | 2011-03-22 | Wyeth Corp | derivados de 3-sulfonilindazol substituìdo como ligantes de 5-hidroxitriptamina-6 |
| JP2009506007A (ja) | 2005-08-25 | 2009-02-12 | エフ．ホフマン−ラ ロシュ アーゲー | ｐ３８ＭＡＰキナーゼ阻害剤及びその使用方法 |
| WO2007029077A1 (en) * | 2005-09-05 | 2007-03-15 | Ranbaxy Laboratories Limited | Substituted indazoles as inhibitors of phosphodiesterase type-iv |
| WO2007031838A1 (en) | 2005-09-16 | 2007-03-22 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| EP1960353B1 (en) * | 2005-11-03 | 2014-03-12 | Allergan, Inc. | Prostaglandins and analogues as agents for lowering intraocular pressure |
| KR20080114688A (ko) | 2006-01-13 | 2008-12-31 | 와이어쓰 | 5-히드록시트립타민 수용체에 대한 리간드로서의 술포닐 치환된 1ｈ-인돌 |
| RU2442777C2 (ru) | 2006-01-31 | 2012-02-20 | Эррэй Биофарма Инк. | Ингибиторы киназ и способы их применения |
| ES2462240T3 (es) | 2006-02-28 | 2014-05-22 | Dart Neuroscience (Cayman) Ltd | Piperazinas terapéuticas como inhibidores de PDE4 |
| WO2007120523A2 (en) * | 2006-03-31 | 2007-10-25 | Vitae Pharmaceuticals, Inc. | 6-(aminoalkyl)indazoles |
| JP2009532471A (ja) * | 2006-04-05 | 2009-09-10 | ワイス | ５−ヒドロキシトリプタミン−６リガンドとしてのスルホニル−３−ヘテロシクリルインダゾール誘導体 |
| WO2007120596A1 (en) * | 2006-04-12 | 2007-10-25 | Wyeth | DIHYDRO[1,4]DIOXINO[2,3-e]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS |
| US8012886B2 (en) * | 2007-03-07 | 2011-09-06 | Asm Assembly Materials Ltd | Leadframe treatment for enhancing adhesion of encapsulant thereto |
| CA2680625C (en) | 2007-03-14 | 2016-02-23 | Ranbaxy Laboratories Limited | Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
| CN102648284B (zh) * | 2009-09-18 | 2014-09-24 | 株式会社里维松 | 多酚衍生物及其制造方法 |
| WO2011143430A1 (en) | 2010-05-12 | 2011-11-17 | Abbott Laboratories | Indazole inhibitors of kinase |
| CN103709146B (zh) * | 2014-01-15 | 2015-11-25 | 中国药科大学 | 一类含苯并咪唑结构的喹啉-4-胺衍生物、其制法及医药用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5006520A (en) * | 1987-10-13 | 1991-04-09 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused pyrazole compounds and pharmaceutical use thereof |
| EP0338087A4 (en) * | 1987-10-13 | 1991-07-24 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused pyrazole compounds, process for their preparation, and their medicinal use |
| US5593997A (en) * | 1995-05-23 | 1997-01-14 | Pfizer Inc. | 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors |
| AP1147A (en) * | 1996-05-03 | 2003-02-25 | Pfizer | Substituted indazole derivatives and related compounds. |
| IL128642A0 (en) * | 1996-09-04 | 2000-01-31 | Pfizer | Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
-
1998
- 1998-10-26 SK SK625-2000A patent/SK6252000A3/sk unknown
- 1998-10-26 NZ NZ503918A patent/NZ503918A/en unknown
- 1998-10-26 ID IDW20000819A patent/ID23921A/id unknown
- 1998-10-26 EP EP98947732A patent/EP1028946A1/en not_active Withdrawn
- 1998-10-26 JP JP2000518952A patent/JP2001521926A/ja active Pending
- 1998-10-26 CN CN98812929A patent/CN1284948A/zh active Pending
- 1998-10-26 TR TR2000/01234T patent/TR200001234T2/xx unknown
- 1998-10-26 YU YU25000A patent/YU25000A/sh unknown
- 1998-10-26 BR BR9813926-6A patent/BR9813926A/pt not_active IP Right Cessation
- 1998-10-26 PL PL98340753A patent/PL340753A1/xx not_active Application Discontinuation
- 1998-10-26 WO PCT/IB1998/001710 patent/WO1999023077A1/en not_active Application Discontinuation
- 1998-10-26 EA EA200000488A patent/EA200000488A1/ru unknown
- 1998-10-26 US US09/381,425 patent/US6391872B1/en not_active Expired - Fee Related
- 1998-10-26 CA CA002309150A patent/CA2309150A1/en not_active Abandoned
- 1998-10-26 AU AU94552/98A patent/AU754734B2/en not_active Ceased
- 1998-10-26 CZ CZ20001621A patent/CZ20001621A3/cs unknown
- 1998-10-26 HU HU0004150A patent/HUP0004150A3/hu unknown
- 1998-10-26 IL IL13590098A patent/IL135900A0/xx unknown
- 1998-10-29 AP APAP/P/1998/001375A patent/AP910A/en active
- 1998-11-03 MA MA25332A patent/MA26563A1/fr unknown
- 1998-11-03 AR ARP980105534A patent/AR013746A1/es not_active Application Discontinuation
- 1998-11-03 TN TNTNSN98200A patent/TNSN98200A1/fr unknown
- 1998-11-03 DZ DZ980250A patent/DZ2640A1/xx active
- 1998-11-03 PE PE1998001041A patent/PE129199A1/es not_active Application Discontinuation
-
2000
- 2000-04-19 IS IS5465A patent/IS5465A/is unknown
- 2000-04-26 NO NO20002129A patent/NO20002129L/no not_active Application Discontinuation
- 2000-04-28 HR HR20000253A patent/HRP20000253A2/hr not_active Application Discontinuation
- 2000-04-28 OA OA1200000127A patent/OA11354A/en unknown
- 2000-05-17 BG BG104450A patent/BG104450A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0004150A2 (hu) | 2001-05-28 |
| DZ2640A1 (fr) | 2003-03-08 |
| IS5465A (is) | 2000-04-19 |
| AU754734B2 (en) | 2002-11-21 |
| CA2309150A1 (en) | 1999-05-14 |
| YU25000A (sh) | 2003-12-31 |
| SK6252000A3 (en) | 2001-11-06 |
| IL135900A0 (en) | 2001-05-20 |
| BG104450A (en) | 2000-12-29 |
| AU9455298A (en) | 1999-05-24 |
| WO1999023077A1 (en) | 1999-05-14 |
| TNSN98200A1 (fr) | 2005-03-15 |
| OA11354A (en) | 2003-12-23 |
| CZ20001621A3 (cs) | 2001-08-15 |
| EP1028946A1 (en) | 2000-08-23 |
| US6391872B1 (en) | 2002-05-21 |
| EA200000488A1 (ru) | 2000-10-30 |
| AR013746A1 (es) | 2001-01-10 |
| PL340753A1 (en) | 2001-02-26 |
| NO20002129L (no) | 2000-07-03 |
| PE129199A1 (es) | 1999-12-16 |
| BR9813926A (pt) | 2000-09-19 |
| AP910A (en) | 2000-12-05 |
| NO20002129D0 (no) | 2000-04-26 |
| NZ503918A (en) | 2002-03-28 |
| AP9801375A0 (en) | 1998-12-31 |
| HRP20000253A2 (en) | 2001-06-30 |
| ID23921A (id) | 2000-05-25 |
| MA26563A1 (fr) | 2004-12-20 |
| JP2001521926A (ja) | 2001-11-13 |
| CN1284948A (zh) | 2001-02-21 |
| TR200001234T2 (tr) | 2000-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0004150A3 (en) | Indazole derivatives as tyrosine kinase receptor antagonists and pharmaceutical compositions containing them | |
| HUP9701714A3 (en) | Indole derivatives neuropeptide y receptor antagonists, use thereof and pharmaceutical compositions containing these compounds | |
| HUP9901245A3 (en) | Indole derivatives useful as endothelin receptor antagonists, preparation and use thereof, pharmaceutical compositions containing these compounds | |
| HUP0203323A3 (en) | Tyrosine kinase inhibitors and pharmaceutical compositions containing them | |
| HUP9901296A3 (en) | Substituted piperidine derivatives as nmda receptor antagonists and pharmaceutical compositions containing them | |
| HUP0004490A2 (en) | Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threoning kinase inhibitors and pharmaceutical compositions containing them | |
| HUP0100266A3 (en) | 1-amino-alkylcyclohexane nmda receptor antagonists, pharmaceutical compositions containing the compounds and their preparations | |
| NZ301265A (en) | Indole derivatives as 5ht receptor antagonists, preparation and pharmaceutical compositions thereof | |
| HUP0202682A3 (en) | Tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use | |
| HUP0201545A2 (en) | Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them | |
| HUP0203638A3 (en) | Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them and their use | |
| HUP9603298A3 (en) | Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation, and their use for the preparation of pharmaceutical compositions | |
| HUP0200130A2 (en) | Substituted pyrazoles as p38 kinase inhibitors and pharmaceutical compositions containing them | |
| HUP0200992A3 (en) | Indoline derivatives as progesterone antagonists and pharmaceutical compositions containing them and their use | |
| IL120141A0 (en) | Substituted quinazoline derivatives and pharmaceutical compositions containing them | |
| HUP0101275A3 (en) | Amide derivatives and pharmaceutical compositions containing them as nociceptin antagonists | |
| NZ307625A (en) | 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists | |
| ZA98691B (en) | Use of central cannabinoid receptor antagonists for the preparation of drugs | |
| IL99246A0 (en) | Angiotensin ii receptor antagonists and pharmaceutical compositions containing them | |
| SI0918059T1 (en) | Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them | |
| IL118325A0 (en) | Integrin receptor antagonists and pharmaceutical compositions containing them | |
| HUP0002324A3 (en) | Benzimidazole derivatives and pharmaceutical compositions containing them | |
| HUP0100607A3 (en) | Thrombin receptor antagonists and pharmaceutical compositions containing them | |
| AU1518595A (en) | Antagonists to insulin receptor tyrosine kinase inhibitor | |
| HUP0002929A3 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same |